About: Early non-invasive ventilation treatment for severe influenza pneumonia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Early non-invasive ventilation treatment for severe influenza pneumonia Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Early non-invasive ventilation treatment for severe influenza pneumonia
Creator	Rello, J Almirall, J Gtei, H1n1 Lorente, L Marqué, A Masclans, J Pé Rez, M Semicyuc, / Socias, L Vidaur, L
Source	Elsevier; Medline; PMC
abstract	Abstract The role of non-invasive ventilation (NIV) in acute respiratory failure caused by viral pneumonia remains controversial. Our objective was to evaluate the use of NIV in a cohort of (H1N1)v pneumonia. Usefulness and success of NIV were assessed in a prospective, observational registry of patients with influenza A (H1N1) virus pneumonia in 148 Spanish intensive care units (ICUs) in 2009–10. Significant variables for NIV success were included in a multivariate analysis. In all, 685 patients with confirmed influenza A (H1N1)v viral pneumonia were admitted to participating ICUs; 489 were ventilated, 177 with NIV. The NIV was successful in 72 patients (40.7%), the rest required intubation. Low Acute Physiology and Chronic Health Evaluation (APACHE) II, low Sequential Organ Failure Assessment (SOFA) and absence of renal failure were associated with NIV success. Success of NIV was independently associated with fewer than two chest X-ray quadrant opacities (OR 3.5) and no vasopressor requirement (OR 8.1). However, among patients with two or more quadrant opacities, a SOFA score ≤7 presented a higher success rate than those with SOFA score >7 (OR 10.7). Patients in whom NIV was successful required shorter ventilation time, shorter ICU stay and hospital stay than NIV failure. In patients in whom NIV failed, the delay in intubation did not increase mortality (26.5% versus 24.2%). Clinicians used NIV in 25.8% of influenza A (H1N1)v viral pneumonia admitted to ICU, and treatment was effective in 40.6% of them. NIV success was associated with shorter hospital stay and mortality similar to non-ventilated patients. NIV failure was associated with a mortality similar to those who were intubated from the start.
has issue date	2013-03-31(xsd:dateTime)
bibo:doi	10.1111/j.1469-0691.2012.03797.x
bibo:pmid	22404211
has license	els-covid
sha1sum (hex)	00325033266973fb091b9beb535090bf94810283
schema:url	https://doi.org/10.1111/j.1469-0691.2012.03797.x
resource representing a document's title	Early non-invasive ventilation treatment for severe influenza pneumonia
has PubMed Central identifier	PMC7128378
has PubMed identifier	22404211
schema:publication	Clinical Microbiology and Infection
resource representing a document's body	covid:00325033266973fb091b9beb535090bf94810283#body_text
is schema:about of	named entity 'objective' named entity 'acute respiratory failure' named entity 'severe' named entity 'TREATMENT' named entity 'COHORT' named entity 'PROSPECTIVE' named entity 'OBJECTIVE' named entity 'ACUTE RESPIRATORY FAILURE' named entity 'OUR' named entity 'SUCCESS' named entity 'VIRAL PNEUMONIA' named entity 'USE OF' named entity 'NON-INVASIVE VENTILATION' named entity 'EVALUATE' named entity 'SEVERE' named entity 'EARLY' named entity 'INFLUENZA PNEUMONIA' named entity 'ASSESSED' named entity 'USEFULNESS' named entity 'NIV' named entity 'NON-INVASIVE VENTILATION' named entity 'CAUSED BY' named entity 'ROLE' named entity 'PNEUMONIA' named entity 'NIV' named entity 'pneumonia' named entity 'non-invasive ventilation' named entity 'pneumonia' named entity 'influenza' named entity 'pneumonia' named entity 'NIV' named entity 'H1N1' named entity 'respiratory failure' named entity '3.5' named entity 'mechanical ventilation' named entity 'pulmonary oedema' named entity 'ICU' named entity 'NIV' named entity 'SPSS' named entity 'organ failure' named entity 'intubation' named entity 'non-invasively' named entity 'SOFA score' named entity 'myalgia' named entity 'MODS' named entity 'SOFA score' named entity 'chronic obstructive pulmonary disease' named entity 'intubated' named entity 'invasive mechanical ventilation' named entity 'NIV' named entity 'H1N1 virus' named entity 'viral pneumonia' named entity 'heterogeneity' named entity 'NIV' named entity 'intubated' named entity 'APACHE' named entity 'ICU' named entity 'acute phase' named entity 'intubation' named entity 'respiratory failure' named entity 'SOFA score' named entity 'alveolar' named entity 'MODS' named entity 'aspirates' named entity 'ICU' named entity 'intubated' named entity 'disease transmission' named entity 'Acinetobacter baumannii' named entity 'sample size' named entity 'influenza virus' named entity 'statistical difference' named entity 'NIV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software